INFLAMMATORY BOWEL DISEASE
Clinical trials for INFLAMMATORY BOWEL DISEASE explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY BOWEL DISEASE trials appear
Sign up with your email to follow new studies for INFLAMMATORY BOWEL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can we give COVID and flu shots together? new study for vulnerable patients
⭐️ VACCINE ⭐️ Recruiting nowThis study looks at the best way to give COVID-19 booster and flu shots to people with weakened immune systems (like those with rheumatoid arthritis, organ transplants, or HIV). It will compare getting both vaccines on the same day versus one month apart, and also test if getting…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: ⭐️ VACCINE ⭐️
Last updated May 08, 2026 12:01 UTC
-
New hope: immune drug tested in patients with both autoimmune disease and cancer
Disease control Recruiting nowThis study is for people who have both an autoimmune disorder (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with othe…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New monitoring program aims to help veterans manage IBD
Disease control Recruiting nowThis study tests a program called Measurement-Based Care (MBC) for veterans with inflammatory bowel disease (IBD). The program uses regular patient surveys to help doctors spot problems early and adjust treatment between clinic visits. Researchers will compare quality of life and…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
Real-World check: can a new drug tame Crohn's and colitis?
Disease control Recruiting nowThis study tracks 220 adults with moderate-to-severe ulcerative colitis or Crohn's disease who are starting guselkumab, a biologic drug. Researchers will measure how many patients achieve remission (symptom control) and whether they can stop using steroids. The goal is to see how…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: Janssen-Cilag Ltd. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New study tracks Real-World success of IBD drug guselkumab
Disease control Recruiting nowThis study follows 400 people with Crohn's disease or ulcerative colitis who are starting guselkumab, a biologic drug. Researchers will measure how many achieve remission and how the drug affects fatigue, quality of life, and daily activities. The goal is to see how well the trea…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: Janssen-Cilag G.m.b.H • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Morning light may soothe Crohn's: new study tests simple therapy
Symptom relief Recruiting nowThis study tests whether morning bright light therapy can improve gut health and quality of life in people with Crohn's disease or ulcerative colitis. Researchers will measure changes in intestinal barrier function, inflammation, and gut bacteria. The study enrolls 30 adults with…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: NA • Sponsor: Rush University Medical Center • Aim: Symptom relief
Last updated May 17, 2026 00:29 UTC
-
Can morning light soothe IBD? new study seeks answers
Symptom relief Recruiting nowThis study tests whether morning light therapy can improve sleep and reduce inflammation in 30 adults with ulcerative colitis who have active inflammation and poor sleep. Participants wear a sleep tracker, complete surveys, and receive one hour of light therapy each morning for f…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
Fake-Fast diet may tame gut inflammation
Symptom relief Recruiting nowThis study tests whether a five-day diet that tricks the body into a fasting state can reduce inflammation and improve quality of life in people with mild to moderate ulcerative colitis. Participants will follow the diet for three cycles while researchers track symptoms like stoo…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated May 06, 2026 16:13 UTC
-
Teens with Crohn's disease may have hidden bone changes, new study reveals
Knowledge-focused Recruiting nowThis study looks at bone health in teenagers recently diagnosed with Crohn's disease compared to healthy teens. Researchers use MRI and other scans to measure bone marrow fat and bone density. The goal is to understand how Crohn's disease affects bones early on, which could help …
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 00:31 UTC
-
New tool helps melanoma patients with autoimmune conditions navigate treatment choices
Knowledge-focused Recruiting nowThis study is testing a new educational tool designed for people with melanoma who also have an autoimmune disease (like rheumatoid arthritis or Crohn's disease) and may receive immune checkpoint inhibitor drugs. Researchers want to see if the tool is easy to use and helpful for …
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 00:31 UTC
-
Could tiny plastics in our bodies trigger bowel disease?
Knowledge-focused Recruiting nowThis study looks at how tiny plastic particles (microplastics) in our environment might affect gut health and inflammation, especially in pregnant women and their families. Researchers will measure microplastics in stool samples and study the gut bacteria of 46 participants. The …
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC
-
Scientists watch immune system at work in IBD to unlock new treatments
Knowledge-focused Recruiting nowThis study looks at how the immune system controls inflammation in the gut for people with Crohn's disease or ulcerative colitis. Up to 1,000 participants, from newborns to age 75, will receive standard medical care while researchers collect blood, tissue, and other samples. The …
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
New IBD drug candidate SPH7854 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug called SPH7854 in 111 healthy volunteers to see if it is safe and how the body processes it. The drug is being developed for inflammatory bowel disease, but this trial does not involve people with the condition. The main goal is to che…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Phase: EARLY_PHASE1 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Knowledge-focused
Last updated May 13, 2026 16:04 UTC
-
Scientists hunt for gut clues to IBD-Depression connection
Knowledge-focused Recruiting nowThis study looks at gut bacteria and related chemicals in 120 adults to understand why inflammatory bowel disease (IBD) and depression often occur together. Researchers will compare three groups: people with both IBD and depression, people with IBD only, and healthy volunteers. T…
Matched conditions: INFLAMMATORY BOWEL DISEASE
Sponsor: Fang Tang • Aim: Knowledge-focused
Last updated May 04, 2026 16:18 UTC